文献速递精神分裂症与精神病性障碍

右旋苯丙胺诱导的纹状体多巴胺能亢进减弱奖赏相关神经激活:一项11C-PHNO PET-fMRI研究

Dexamphetamine-induced striatal hyperdopaminergia attenuates reward-related neural activation: A11C-PHNO PET-fMRI study.
PubMed 文献 · Biol Psychiatry · 2026-09-08

该研究对28名健康志愿者进行双盲随机交叉设计的11C-PHNO PET-fMRI扫描,比较安慰剂与口服右旋苯丙胺0.5 mg/kg条件下纹状体多巴胺释放与奖赏相关神经编码的关系。结果发现右旋苯丙胺减弱腹侧纹状体对情境相关奖赏预期的激活,且个体间基线D2/3受体结合潜力越高,腹侧纹状体奖赏编码越强。提示多巴胺水平升高可能通过降低目标相关信息的放大而损害动机编码。

要点

  • 右旋苯丙胺减弱腹侧纹状体对情境相关奖赏预期的激活。
  • 个体间基线11C-PHNO BPND越高,腹侧纹状体奖赏编码越强。
  • 多巴胺升高可能通过降低目标相关信息放大损害动机编码。

核心结论

  • 多巴胺水平升高可能通过减弱对目标相关信息的放大而损害动机编码,或与冷漠和快感缺失等阴性症状相关。

研究设计与样本

  • 健康志愿者N=28,采用双盲随机交叉设计,进行安慰剂与口服右旋苯丙胺0.5 mg/kg两种条件下的同步11C-PHNO PET-fMRI扫描。

主要发现

  • 任务表现良好,未观察到药物对行为的影响。
  • 安慰剂条件下腹侧纹状体对情境相关价值比无关价值的激活更强。
  • 右旋苯丙胺显著减弱该效应,源于对相关线索的腹侧纹状体反应降低而非对无关特征反应增加。
  • 右旋苯丙胺还降低腹侧纹状体结果相关反应,在vmPFC中不显著。
  • 跨 session 个体间11C-PHNO BPND越高,腹侧纹状体奖赏预期和结果编码越强;个体内BPND偏差未解释药物条件外的额外方差。

临床怎么用

  • 该机制提示多巴胺升高可能削弱目标相关信息放大,临床可关注与冷漠、快感缺失等阴性症状的关联。

局限性

  • 研究仅纳入健康志愿者,未直接验证精神病患者中的因果机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ventral striatum (VS) and ventromedial prefrontal cortex (vmPFC) encode the value of stimulus and outcome phases in a context-dependent manner to support motivated behaviour. In psychosis, disrupted motivational coding has been hypothesised to contribute to negative symptoms via reduced sensitivity to goal-relevant information, potentially linked to elevated striatal dopamine. Direct causal evidence for this mechanism in humans remains limited. METHODS: Healthy volunteers (N=28) underwent two simultaneous [11C]-PHNO PET-fMRI sessions (placebo; oral dexamphetamine 0.5 mg/kg, double-blind, randomised crossover). During scanning, participants performed a decision-making task requiring trial-by-trial use of contextual cues to discriminate reward-predictive (relevant) from non-predictive (irrelevant) stimulus features. fMRI quantified context-relevant value coding during reward anticipation and positive-negative outcome responses. PET quantified D2/3 agonist binding potential (BPND) and dexamphetamine-induced dopamine release (ΔBPND). Mixed-effects models related BOLD responses to between- and within-subject components of BPND. RESULTS: Task performance was high with no behavioural drug effects. Under placebo, VS showed greater activation to context-relevant versus irrelevant value during anticipation. Dexamphetamine significantly attenuated this effect, driven by reduced VS responses to relevant cues without increased responses to irrelevant features. Dexamphetamine also reduced outcome-related responses in VS; non-significantly in vmPFC. Across sessions, higher between-subject [11C]-PHNO BPND was associated with stronger VS reward coding during anticipation and outcome, whereas within-subject BPND deviations did not explain additional variance beyond drug condition. CONCLUSIONS: These findings support a mechanism by which elevated dopamine may impair motivational coding by reducing amplification of goal-relevant information, with potential relevance to negative symptoms such as apathy and anhedonia.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Zauchenberger CZ, Vano LJ, Veronese M, et al. Dexamphetamine-induced striatal hyperdopaminergia attenuates reward-related neural activation: A11C-PHNO PET-fMRI study. Biol Psychiatry. 2026. PMID: 42710822. doi:10.1016/j.biopsych.2026.08.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。